Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through open-market transactions.

Between 8 June 2026 and 14 July 2026, Weigao Holding acquired 15.60 million H shares, equivalent to 0.34% of both the company’s issued H-share capital and total share capital.

Aggregating these trades with purchases made since 13 May 2026, the controlling shareholder has accumulated 30.55 million H shares for a total consideration of approximately HK$101.00 million. This represents 0.68% of Weigao Group’s issued H shares and 0.67% of its overall issued share capital.

Following the latest transactions, Weigao Holding holds 2.13 billion H shares, translating to 47.11% of Weigao Group’s issued H shares and 46.61% of the company’s total issued shares.

The company stated that the additional investment underscores Weigao Holding’s confidence in Weigao Group’s long-term prospects. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.